Frequently Asked Questions for PAR-10-005 NHLBI Clinical Trial Pilot Studies (R34)

Notice Number: NOT-HL-11-118

Key Dates

Release Date: September 9, 2010

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

On January 6, 2010, the NHLBI issued an update to the Funding Opportunity Announcements (FOA): PAR-10-005 (NHLBI Clinical Trial Pilot Studies [R34]) http://grants.nih.gov/grants/guide/pa-files/PAR-10-005.html.

As a result of discussions with potential applicants, a list of Frequently Asked Questions (FAQs) has been developed.

The FAQs for this FOA can be found at: http://www.nhlbi.nih.gov/funding/inits/faq-PAR-10-005.html.  This information may be updated periodically without additional notice.  NHLBI staff will also respond to questions submitted by potential applicants who contact the Program, Grants Management, and Review staff listed in the FOA in the Agency Contacts section.

All other aspects of this FOA remain unchanged.

Inquiries

Inquiries should be directed to:

David J. Gordon, M.D., Ph.D.
Division of Cardiovascular Science
National Heart, Lung, and Blood Institute
6701 Rockledge Dr., Room 8134, MSC 7940
Bethesda, MD 20892-7940
Telephone: (301) 435-0564
Fax: (301) 480-7921
Email: [email protected]

Gail G. Weinmann, M.D.
Division of Lung Diseases
National Heart, Lung, and Blood Institute
6701 Rockledge Dr.
Room 10140, MSC 7952
Bethesda, MD 20892-7952
Telephone: (301) 435-0233
Fax: (301) 480-3547
Email: [email protected]

Andrei L. Kindzelski, M.D., Ph.D.
Division of Blood Diseases and Resources
National Heart, Lung, and Blood Institute
6701 Rockledge Dr.
Room 9170, MSC 7950
Bethesda, MD 20892-7950
Telephone: (301) 435-0070
Fax: (301) 480-1046
Email: [email protected]